Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Short Interest Update

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) saw a large growth in short interest in the month of August. As of August 14th, there was short interest totaling 1,098 shares, a growth of 237.8% from the July 30th total of 325 shares. Based on an average trading volume of 3,918 shares, the short-interest ratio is currently 0.3 days. Approximately 0.1% of the shares of the company are sold short.

Fidelity Disruptive Medicine ETF Stock Down 0.5%

Shares of NASDAQ:FMED opened at $32.49 on Thursday. The company has a market cap of $51.98 million, a price-to-earnings ratio of 41.33 and a beta of 0.75. The firm’s 50-day simple moving average is $29.23 and its 200-day simple moving average is $26.55. Fidelity Disruptive Medicine ETF has a fifty-two week low of $23.48 and a fifty-two week high of $32.89.

Institutional Investors Weigh In On Fidelity Disruptive Medicine ETF

A number of hedge funds have recently added to or reduced their stakes in FMED. Virtu Financial LLC acquired a new position in Fidelity Disruptive Medicine ETF during the 4th quarter worth approximately $228,000. Vise Technologies Inc. acquired a new stake in shares of Fidelity Disruptive Medicine ETF in the 4th quarter valued at approximately $234,000. Finally, Jane Street Group LLC lifted its holdings in shares of Fidelity Disruptive Medicine ETF by 0.8% in the 1st quarter. Jane Street Group LLC now owns 66,382 shares of the company’s stock valued at $1,567,000 after buying an additional 499 shares during the period.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.